Free Trial

Insider Buying: Amrize (NYSE:AMRZ) CEO Buys 60,000 Shares of Stock

Amrize logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • CEO Jan Philipp Jenisch bought 60,000 shares at an average price of $58.05 on March 6, spending $3.483 million and increasing his direct stake to 1,703,582 shares (a 3.65% ownership rise), as disclosed in an SEC filing.
  • Shares traded down about 1% to $57.54; Amrize reported quarterly EPS of $0.62 (beating estimates) but revenue of $2.84 billion missed consensus and was down 0.4% year-over-year, with a market cap of $31.83 billion and a P/E of 23.39.
  • Large institutional investors (including Vanguard, Norges Bank, Dodge & Cox and others) have taken sizable new positions, and analysts collectively rate the stock a Moderate Buy with a consensus target around $64.14 and several $66–$70 price targets.
  • Interested in Amrize? Here are five stocks we like better.

Amrize Ltd (NYSE:AMRZ - Get Free Report) CEO Jan Philipp Jenisch purchased 60,000 shares of the business's stock in a transaction dated Friday, March 6th. The shares were purchased at an average cost of $58.05 per share, for a total transaction of $3,483,000.00. Following the purchase, the chief executive officer directly owned 1,703,582 shares of the company's stock, valued at $98,892,935.10. This trade represents a 3.65% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Amrize Trading Down 1.0%

Shares of AMRZ traded down $0.58 during trading hours on Monday, reaching $57.54. The stock had a trading volume of 3,409,438 shares, compared to its average volume of 3,558,664. The firm has a 50-day moving average of $57.64 and a 200 day moving average of $53.47. The company has a quick ratio of 1.10, a current ratio of 1.64 and a debt-to-equity ratio of 0.37. The company has a market cap of $31.83 billion and a P/E ratio of 23.39. Amrize Ltd has a 52 week low of $44.12 and a 52 week high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last issued its quarterly earnings data on Tuesday, February 17th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.59 by $0.03. The company had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. Amrize's revenue for the quarter was down .4% compared to the same quarter last year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. bought a new stake in shares of Amrize during the 2nd quarter valued at $1,065,029,000. Norges Bank purchased a new stake in Amrize in the fourth quarter worth about $929,333,000. Dodge & Cox bought a new position in shares of Amrize in the second quarter worth about $622,085,000. Harris Associates L P purchased a new position in shares of Amrize during the 4th quarter valued at about $615,406,000. Finally, JPMorgan Chase & Co. purchased a new stake in Amrize in the 2nd quarter worth approximately $220,404,000.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on AMRZ. Bank of America set a $58.00 price objective on shares of Amrize in a report on Monday, January 12th. Citigroup upped their price objective on Amrize from $63.00 to $67.00 and gave the stock a "buy" rating in a report on Thursday, January 8th. Wells Fargo & Company raised their price objective on Amrize from $59.00 to $66.00 and gave the company an "overweight" rating in a report on Thursday, February 19th. Berenberg Bank set a $70.00 target price on Amrize in a research note on Thursday, February 19th. Finally, Sanford C. Bernstein reissued an "outperform" rating and set a $70.00 price target on shares of Amrize in a research note on Thursday, December 18th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $64.14.

Read Our Latest Stock Report on Amrize

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Featured Articles

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amrize Right Now?

Before you consider Amrize, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.

While Amrize currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines